Y-mAbs Therapeutics, Inc. Operating Income
Y-mAbs Therapeutics, Inc. reported Operating Income of -$5.60 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-08-08
- Y-mAbs Therapeutics, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$5.60M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$6.54M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$5.94M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$8.57M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$31.20M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$25.67M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$94.81M.
- Y-mAbs Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$115.43M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$5.60M 10-Q · filed 2025-08-08 | -$12.15M 10-Q · filed 2025-08-08 | -$18.08M derived: sum of 3 quarters · filed 2025-08-08 | -$26.65M derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | -$6.54M 10-Q · filed 2025-05-13 | -$12.48M derived: sum of 2 quarters · filed 2025-05-13 | -$21.05M derived: sum of 3 quarters · filed 2025-05-13 | -$30.84M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | -$5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$14.50M derived: sum of 2 quarters · filed 2025-03-04 | -$24.29M derived: sum of 3 quarters · filed 2025-08-08 | -$31.20M 10-K · filed 2025-03-04 |
| 2024-09-30 | -$8.57M 10-Q · filed 2024-11-08 | -$18.36M derived: sum of 2 quarters · filed 2025-08-08 | -$25.27M 10-Q · filed 2024-11-08 | -$28.46M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -$9.79M 10-Q · filed 2025-08-08 | -$16.70M 10-Q · filed 2025-08-08 | -$19.90M derived: sum of 3 quarters · filed 2025-08-08 | -$27.64M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$6.91M 10-Q · filed 2025-05-13 | -$10.11M derived: sum of 2 quarters · filed 2025-05-13 | -$17.86M derived: sum of 3 quarters · filed 2025-05-13 | -$25.08M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$10.95M derived: sum of 2 quarters · filed 2025-03-04 | -$18.17M derived: sum of 3 quarters · filed 2025-03-04 | -$25.67M 10-K · filed 2025-03-04 |
| 2023-09-30 | -$7.75M 10-Q · filed 2024-11-08 | -$14.97M derived: sum of 2 quarters · filed 2024-11-08 | -$22.47M 10-Q · filed 2024-11-08 | -$23.63M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$7.22M 10-Q · filed 2024-08-12 | -$14.72M 10-Q · filed 2024-08-12 | -$15.88M derived: sum of 3 quarters · filed 2024-08-12 | -$41.89M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$7.50M 10-Q · filed 2024-05-07 | -$8.65M derived: sum of 2 quarters · filed 2024-05-07 | -$34.67M derived: sum of 3 quarters · filed 2024-05-07 | -$74.62M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$27.17M derived: sum of 2 quarters · filed 2024-02-29 | -$67.11M derived: sum of 3 quarters · filed 2024-02-29 | -$94.81M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$26.02M 10-Q · filed 2023-11-13 | -$65.96M derived: sum of 2 quarters · filed 2023-11-13 | -$93.66M 10-Q · filed 2023-11-13 | -$129.41M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$39.95M 10-Q · filed 2023-08-10 | -$67.64M 10-Q · filed 2023-08-10 | -$103.40M derived: sum of 3 quarters · filed 2023-08-10 | -$132.10M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$27.70M 10-Q · filed 2023-05-08 | -$63.45M derived: sum of 2 quarters · filed 2023-05-08 | -$92.16M derived: sum of 3 quarters · filed 2023-05-08 | -$114.87M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$35.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$64.46M derived: sum of 2 quarters · filed 2023-03-30 | -$87.17M derived: sum of 3 quarters · filed 2023-03-30 | -$115.43M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$28.70M 10-Q · filed 2022-11-07 | -$51.42M derived: sum of 2 quarters · filed 2022-11-07 | -$79.67M 10-Q · filed 2022-11-07 | -$99.77M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$22.71M 10-Q · filed 2022-08-08 | -$50.97M 10-Q · filed 2022-08-08 | -$71.07M derived: sum of 3 quarters · filed 2022-08-08 | -$103.71M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$28.26M 10-Q · filed 2022-05-09 | -$48.35M derived: sum of 2 quarters · filed 2022-05-09 | -$81.00M derived: sum of 3 quarters · filed 2022-05-09 | -$121.45M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$20.09M 10-K · filed 2021-03-01 | -$52.74M derived: sum of 2 quarters · filed 2021-11-04 | -$93.19M derived: sum of 3 quarters · filed 2021-11-04 | -$119.94M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$32.64M 10-Q · filed 2021-11-04 | -$73.09M derived: sum of 2 quarters · filed 2021-11-04 | -$99.84M 10-Q · filed 2021-11-04 | -$123.60M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$40.45M 10-Q · filed 2021-08-09 | -$67.20M 10-Q · filed 2021-08-09 | -$90.96M derived: sum of 3 quarters · filed 2021-08-09 | -$115.32M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$26.75M 10-Q · filed 2021-05-06 | -$50.51M derived: sum of 2 quarters · filed 2021-05-06 | -$74.86M derived: sum of 3 quarters · filed 2021-05-06 | -$93.50M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$23.76M 10-K · filed 2021-03-01 | -$48.12M derived: sum of 2 quarters · filed 2021-03-01 | -$66.75M derived: sum of 3 quarters · filed 2021-03-01 | -$83.00M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$24.36M 10-K · filed 2021-03-01 | -$42.99M derived: sum of 2 quarters · filed 2021-03-01 | -$59.25M 10-Q · filed 2020-11-05 | -$73.32M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$18.63M 10-K · filed 2021-03-01 | -$34.89M 10-Q · filed 2020-08-06 | -$48.97M derived: sum of 3 quarters · filed 2021-03-01 | -$60.38M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$16.25M 10-K · filed 2021-03-01 | -$30.33M derived: sum of 2 quarters · filed 2021-03-01 | -$41.75M derived: sum of 3 quarters · filed 2021-03-01 | -$52.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$14.08M 10-K · filed 2020-03-12 | -$25.49M derived: sum of 2 quarters · filed 2020-03-12 | -$35.75M derived: sum of 3 quarters · filed 2020-03-12 | -$43.23M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$11.41M 10-K · filed 2020-03-12 | -$21.67M derived: sum of 2 quarters · filed 2020-03-12 | -$29.15M 10-Q · filed 2019-11-13 | -$38.43M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$10.26M 10-K · filed 2020-03-12 | -$17.74M 10-Q · filed 2019-08-14 | -$27.01M derived: sum of 3 quarters · filed 2020-03-12 | -$30.85M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$7.48M 10-K · filed 2020-03-12 | -$16.75M derived: sum of 2 quarters · filed 2020-03-12 | -$20.60M derived: sum of 3 quarters · filed 2020-03-12 | -$23.83M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$9.28M 10-K · filed 2019-03-22 | -$13.12M derived: sum of 2 quarters · filed 2019-03-22 | -$16.35M derived: sum of 3 quarters · filed 2019-03-22 | -$19.24M 10-K · filed 2019-03-22 |
| 2017-09-30 | -$3.84M 10-K · filed 2019-03-22 | -$7.07M derived: sum of 2 quarters · filed 2019-03-22 | -$9.97M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$3.23M 10-K · filed 2019-03-22 | -$6.13M derived: sum of 2 quarters · filed 2019-03-22 | ||
| 2017-03-31 | -$2.90M 10-K · filed 2019-03-22 |